Propofol infusion syndrome in the ICU

Journal of Intensive Care Medicine

Volumn 26, Issue 2, 2011, Pages 59-72

  Diedrich, Daniel A ^a   Brown, Daniel R ^a  

^a Mayo Clinic   (United States)

Author keywords

cardiovascular collapse; lactic acidosis; propofol; Propofol infusion syndrome; rhabdomyolysis; sedation

Indexed keywords

ETIRACETAM; FOSPHENYTOIN SODIUM; LORAZEPAM; PHENOBARBITAL; PHENYLEPHRINE; PROPOFOL; HYPNOTIC SEDATIVE AGENT;

ADD ON THERAPY; ADULT; ARTIFICIAL VENTILATION; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL FEATURE; COMPLEX PARTIAL SEIZURE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EXTRACORPOREAL OXYGENATION; FEMALE; HEPATOMEGALY; HUMAN; INTENSIVE CARE UNIT; KIDNEY DISEASE; LABORATORY TEST; MALE; METABOLIC DISORDER; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT MONITORING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RESPIRATORY TRACT DISEASE; RESUSCITATION; REVIEW; RHABDOMYOLYSIS; TACHYCARDIA; ARTICLE; CHEMICALLY INDUCED DISORDER; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; SEIZURE; SYNDROME;

ADULT; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROPOFOL; SEIZURES; SYNDROME;

EID: 79953878354     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610384195     Document Type: Review

References (92)

1. Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008;14(2):95-106. (Pubitemid 351713319)
2. Lalwani K, Michel M. Pediatric sedation in North American children's hospitals: a survey of anesthesia providers. Paediatr Anaesth. 2005;15(3):209-213. (Pubitemid 40364746)
3. Byrne MF, Chiba N, Singh H, Sadowski DC. Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement. Can J Gastroenterol. 2008;22(5):457-459. (Pubitemid 351943673)
4. Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology. 2007;133(2):675-701. (Pubitemid 47193131)
5. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119-141. (Pubitemid 34112188)
6. White PF. Propofol: its role in changing the practice of anesthesia. Anesthesiology. 2008;109(6):1132-1136.
7. Rogers KM, Dewar KM, McCubbin TD, Spence AA. Preliminary experience with ICI 35 868 as an i.v. induction agent: comparison with althesin. Br J Anaesth. 1980;52(8):807-810. (Pubitemid 10090450)
8. Rutter DV, Morgan M, Lumley J, Owen R. ICI 35868 (Diprivan): a new intravenous induction agent. A comparison with methohexitone. Anaesthesia. 1980;35(12):1188-1192.
9. Doze VA, Westphal LM,White PF. Comparison of propofol with methohexital for outpatient anesthesia. Anesth Analg. 1986;65(11):1189-1195. (Pubitemid 16005552)
10. Wysowski DK, Pollock ML. Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review. Anesthesiology. 2006;105(5):1047-1051. (Pubitemid 44655517)
11. White PF, Negus JB. Sedative infusions during local and regional anesthesia: a comparison of midazolam and propofol. J Clin Anesth. 1991;3(1):32-39.
12. Notis fra Bivirkningsnaenet. Propofol (Diprivan) bivirkninger. Ugeskr Laeger. 1990;152:1176.
13. Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ. 1992;305(6854):613-616.
14. Cook S. Propofol infusion in children. BMJ. 1992;305(6859):953-954.
15. United States Food and Drug Administration Center for Drug Evaluation and Research (Anesthetic and Life Support Drugs Advisory Committee). ICI's Diprivan (propofol) anesthetic has no direct link to pediatric deaths in ICU's. FDC Reports. 1992;54:14.
16. Ahlen K, Buckley CJ, Goodale DB, Pulsford AH. The 'propofol infusion syndrome': the facts, their interpretation and implications for patient care. Eur J Anaesthesiol. 2006;23(12):990-998. (Pubitemid 44622925)
17. Barclay K, Williams AJ, Major E. Propofol infusion in children. BMJ. 1992;305(6859):953-954.
18. MCA/CSM. Serious adverse effects and fatalities in children associated with the use of propofol (Diprivan) for sedation. Curr Problems Pharmacovilance. 1992;34:4.
19. Rosen DJ, Nicoara A, Koshy N, Wedderburn RV. Too much of a good thing? Tracing the history of the propofol infusion syndrome. J Trauma. 2007;63(2):443-447. (Pubitemid 47254674)
20. Bodd E, Endresen L. Use of propofol for children. Tidsskr Nor Laegeforen. 1992;112:1636-1637.
21. Strickland RA, Murray MJ. Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship? Crit Care Med. 1995;23(2):405-409.
22. Bray RJ. Fatal myocardial failure associated with a propofol infusion in a child. Anaesthesia. 1995;50(1):94.
23. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth. 1998;8(6):491-499. (Pubitemid 28523410)
24. Plotz FB, Waalkens HJ, Verkade HJ, Strengers JL, Knoester H, Mandema JM. Fatal side-effects of continuous propofol infusion in children may be related to malignant hyperthermia. Anaesth Intensive Care. 1996;24(6):724. (Pubitemid 27010730)
25. Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology. 1998;50(1):301-303. (Pubitemid 28106063)
26. Cannon ML, Glazier SS, Bauman LA. Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion. J Neurosurg. 2001;95(6):1053-1056. (Pubitemid 33123867)
27. Holzki J, Aring C, Gillor A. Death after re-exposure to propofol in a 3-year-old child: a case report. Paediatr Anaesth. 2004;14(3):265-270. (Pubitemid 38373065)
28. Baumeister FA, Oberhoffer R, Liebhaber GM, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics. 2004;35(4):250-252. (Pubitemid 39215606)
29. Sabsovich I, Rehman Z, Yunen J, Coritsidis G. Propofol infusion syndrome: a case of increasing morbidity with traumatic brain injury. Am J Crit Care. 2007;16(1):82-85.
30. Kelly DF. Propofol-infusion syndrome. J Neurosurg. 2001;95(6):925-926. (Pubitemid 33123846)
31. Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Crit Care Med. 2000;28(8):3071-3074.
32. Eriksen J, Povey HM. A case of suspected non-neurosurgical adult fatal propofol infusion syndrome. Acta Anaesthesiol Scand. 2006;50(1):117-119. (Pubitemid 43339041)
33. Badr AE, Mychaskiw G 2nd, Eichhorn JH. Metabolic acidosis associated with a new formulation of propofol. Anesthesiology. 2001;94(3):536-538. (Pubitemid 32198468)
34. Friedman JA, Manno E, Fulgham JR. Propofol. J Neurosurg. 2002;96(6):1161-1162.
35. Kumar MA, Urrutia VC, Thomas CE, Abou-Khaled KJ, Schwartzman RJ. The syndrome of irreversible acidosis after prolonged propofol infusion. Neurocrit Care. 2005;3(3):257-259. (Pubitemid 43004823)
36. Merz TM, Regli B, Rothen HU, Felleiter P. Propofol infusion syndrome - a fatal case at a low infusion rate. Anesth Analg. 2006;103(4):1050. (Pubitemid 44576741)
37. Zarovnaya EL, Jobst BC, Harris BT. Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. Epilepsia. 2007;48(5):1002-1006. (Pubitemid 46763414)
38. Ernest D, French C. Propofol infusion syndrome-report of an adult fatality. Anaesth Intensive Care. 2003;31(3):316-319. (Pubitemid 36805959)
39. Casserly B, O'Mahony E, Timm EG, Haqqie S, Eisele G, Urizar R. Propofol infusion syndrome: an unusual cause of renal failure. Am J Kidney Dis. 2004;44(6):e98-e101. (Pubitemid 39556471)
40. Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem. 2000;46(4):577-581. (Pubitemid 30210736)
41. Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357(9250):117-118. (Pubitemid 32094917)
42. Felmet K, Nguyen T, Clark RS, Orr D, Carcillo J. The FDA warning against prolonged sedation with propofol in children remains warranted. Pediatrics. 2003;112(4):1002-1003. (Pubitemid 37248722)
43. Withington DE, Decell MK, Al Ayed T. A case of propofol toxicity: further evidence for a causal mechanism. Paediatr Anaesth. 2004;14(6):505-508. (Pubitemid 38758673)
44. Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62(7):690-701. (Pubitemid 46929963)
45. Marinella MA. Lactic acidosis associated with propofol. Chest. 1996;109(1):292.
46. Cravens GT, Packer DL, Johnson ME. Incidence of propofol infusion syndrome during noninvasive radiofrequency ablation for atrial flutter or fibrillation. Anesthesiology. 2007;106(6):1134-1138. (Pubitemid 46828166)
47. Rozet I, Lam AM. Propofol infusion syndrome or probable overinterpretation syndrome? Anesthesiology. 2008;108(2):330.
48. Gallart L, Bermejo S, Silva-Costa-Gomes T, Puig MM. Propofol infusion and lactic acidosis. Anesthesiology. 2008;108(2):331.
49. Fong JJ, Sylvia L, Ruthazer R, Schumaker G, Kcomt M, Devlin JW. Predictors of mortality in patients with suspected propofol infusion syndrome. Crit Care Med. 2008;36(8):2281-2287.
50. Richardson J. Propofol infusion for coronary artery bypass surgery in a patient with suspected malignant hyperpyrexia. Anaesthesia. 1987;42(10):1125.
51. Allen G. Propofol and malignant hyperthermia. Anesth Analg. 1991;73(3):359.
52. Short TG, Young Y. Toxicity of intravenous anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17(1):77-89. (Pubitemid 38950014)
53. Murray RK, Knovel (Firm). Harper's Illustrated Biochemistry. 26th ed. New York, NY: McGraw-Hill; 2003.
54. Wolf A, Weir P, Segar P, Stone J, Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001;357(9256):606-607. (Pubitemid 32179617)
55. Fodale V, La Monaca E. Propofol infusion syndrome: an overview of a perplexing disease. Drug Saf. 2008;31(4):293-303. (Pubitemid 351441578)
56. Schenkman KA, Yan S. Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit Care Med. 2000;28(1):172-177. (Pubitemid 30091048)
57. Branca D, Roberti MS, Lorenzin P, Vincenti E, Scutari G. Influence of the anesthetic 2,6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria. Biochem Pharmacol. 1991;42(1):87-90.
58. Cray SH, Robinson BH, Cox PN. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med. 1998;26(12):2087-2092. (Pubitemid 29016695)
59. Wolf AR, Potter F. Propofol infusion in children: when does an anesthetic tool become an intensive care liability? Paediatr Anaesth. 2004;14(6):435-438.
60. Mehta N, DeMunter C, Habibi P, Nadel S, Britto J. Short-term propofol infusions in children. Lancet. 1999;354(9181):866-867.
61. Jouven X, Charles MA, Desnos M, Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation. 2001;104(7):756-761. (Pubitemid 32762671)
62. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29(9):1417-1425. (Pubitemid 37153585)
63. Vernooy K, Delhaas T, Cremer OL, et al. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm. 2006;3(2):131-137. (Pubitemid 43149982)
64. Makiguchi M. [Studies on the mechanism of arrhythmogenic action of free fatty acid]. Hokkaido Igaku Zasshi. 1988;63(4):624-634.
65. Makiguchi M, Kawaguchi H, Tamura M, Yasuda H. Effect of palmitic acid and fatty acid binding protein on ventricular fibrillation threshold in the perfused rat heart. Cardiovasc Drugs Ther. 1991;5(4):753-761.
66. Zhou J, Tian M, Zhou ZN. [Inhibition of transient outward potassium current in rat ventricular myocytes by propofol]. Sheng Li Xue Bao. 1997;49(1):99-101.
67. Zhou W, Fontenot HJ, Liu S, Kennedy RH. Modulation of cardiac calcium channels by propofol. Anesthesiology. 1997;86(3):670-675. (Pubitemid 27118351)
68. Zhou W, Fontenot HJ, Wang SN, Kennedy RH. Propofol-induced alterations in myocardial beta-adrenoceptor binding and responsiveness. Anesth Analg. 1999;89(3):604-608. (Pubitemid 29409804)
69. DiMauro S. Mitochondrial myopathies. Curr Opin Rheumatol. 2006;18(6):636-641. (Pubitemid 44607420)
70. Zoraster RM, Rison RA. Severe lactic acidosis secondary to minocycline in a teenager with infectious mononucleosis and mitochondrial myopathy. Clin Neurol Neurosurg. 2008;110(6):627-630.
71. Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord. 2004;14(4):237-245.
72. Feillet F, Steinmann G, Vianey-Saban C, et al. Adult presentation of MCAD deficiency revealed by coma and severe arrythmias. Intensive Care Med. 2003;29(9):1594-1597. (Pubitemid 37153607)
73. Maier EM, Liebl B, Roschinger W, et al. Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. Hum Mutat. 2005;25(5):443-452. (Pubitemid 40675293)
74. Fudickar A, Bein B, Tonner PH. Propofol infusion syndrome in anaesthesia and intensive care medicine. Curr Opin Anaesthesiol. 2006;19(4):404-410. (Pubitemid 44048262)
75. Nishiyama T, Hanaoka K. Propofol-induced bronchoconstriction: two case reports. Anesth Analg. 2001;93(3):645-646. (Pubitemid 32783288)
76. Eames WO, Rooke GA, Wu RS, Bishop MJ. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology. 1996;84(6):1307-1311. (Pubitemid 26192037)
77. Bodenham A, Culank LS, Park GR. Propofol infusion and green urine. Lancet. 1987;2(8561):740. (Pubitemid 17125709)
78. Kato N, Ogawa R. Does use of propofol in heavy alcohol drinkers tend to discolor their urine? Acta Anaesthesiol Scand. 1999;43(8):868-869.
79. Karakitsos D, Poularas J, Kalogeromitros A, Karabinis A. The propofol infusion syndrome treated with haemofiltration. Is there a time for genetic screening? Acta Anaesthesiol Scand. 2007;51(5):644-645.
80. Betrosian AP, Papanikoleou M, Frantzeskaki F, Diakalis C, Georgiadis G. Myoglobinemia and propofol infusion. Acta Anaesthesiol Scand. 2005;49(5):720.
81. Salengros JC, Engelman E. Myoglobinemia and propofol infusion. Acta Anaesthesiol Scand. 2006;50(1):125-126.
82. Laquay N, Pouard P, Silicani MA, Vaccaroni L, Orliaguet G. Early stages of propofol infusion syndrome in paediatric cardiac surgery: two cases in adolescent girls. Br J Anaesth. 2008;101(6):880-881.
83. Koch M, De Backer D, Vincent JL. Lactic acidosis: an early marker of propofol infusion syndrome? Intensive Care Med. 2004;30(3):522.
84. Haase R, Sauer H, Eichler G. Lactic acidosis following short-term propofol infusion may be an early warning of propofol infusion syndrome. J Neurosurg Anesthesiol. 2005;17(2):122-123. (Pubitemid 40602765)
85. Fudickar A, Tonner PH, Mihaljovic Z, et al. Suggested beginning of propofol infusion syndrome in an adult patient without lactacidosis: a case report. Eur J Anaesthesiol. 2008;25(9):777-778.
86. Ypsilantis P, Politou M, Mikroulis D, et al. Organ toxicity and mortality in propofol-sedated rabbits under prolonged mechanical ventilation. Anesth Analg. 2007;105(1):155-166. (Pubitemid 46975862)
87. Otterspoor LC, Kalkman CJ, Cremer OL. Update on the propofol infusion syndrome in ICU management of patients with head injury. Curr Opin Anaesthesiol. 2008;21(5):544-551.
88. Cornfield DN, Tegtmeyer K, Nelson MD, Milla CE, Sweeney M. Continuous propofol infusion in 142 critically ill children. Pediatrics. 2002;110(6):1177-1181. (Pubitemid 35425194)
89. Machata AM, Gonano C, Birsan T, Zimpfer M, Spiss CK. Rare but dangerous adverse effects of propofol and thiopental in intensive care. J Trauma. 2005;58(3):643-645. (Pubitemid 40365834)
90. Takasu A, Iwamoto S, Ando S, et al. Effects of various concentrations of inhaled oxygen on tissue dysoxia, oxidative stress, and survival in a rat hemorrhagic shock model. Resuscitation. 2009;80(7):826-831.
91. Culp KE, Augoustides JG, Ochroch AE, Milas BL. Clinical management of cardiogenic shock associated with prolonged propofol infusion. Anesth Analg. 2004;99(1):221-226. (Pubitemid 38808194)
92. Abrahams JM, Reiter GT, Acker MA, Sinson GP. Propofol. J Neurosurg. 2002;96(6):1160-1161.